miami glp-1 lawsuit Lipsitz, Ponterio & Comerford Drugmaker warns copycat GLP-1 drugs

Its not surprising, then, that results from Mercers National Survey of Employer-Sponsored Health Plans 2023 show that fewer than half of large employers (42% of those with 500 or more employees) currently cover GLP-1 medications for treatment of obesity, although another 19% say they are considering it

Double-check the information on the prescription vial or pen, including the dose amount and expiration date

In our respective medical societies, we may have opportunities to help advocate for better access

in this context, the enhanced accumulation of specific metabolites is also of great interest (Li et al

Final Verdict Kojic acid and alpha arbutin are both effective, well-researched brightening ingredients

That is a pretty crowded bench, so let us walk through what matters most and where the marketing stops being helpful